Explore /
Poster
/ Biochemical recurrence (BCR) surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate (BCRSCRAP): A meta-analysis from MARCAP Consortium.

Biochemical recurrence (BCR) surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate (BCRSCRAP): A meta-analysis from MARCAP Consortium.

Authors

Soumyajit Roy

Rush University Medical Center, Chicago, IL

Soumyajit Roy , Tahmineh Romero , Allison Steigler , James William Denham , David John Joseph , Jeff M. Michalski , Felix Y Feng , Michel Bolla , Theo M. de Reijke , Philippe Maingon , Matthew R. Sydes , David P. Dearnaley , Luca Incrocci , Wilma Heemsbergen , Abdenour Nabid , Luis Souhami , Almudena Zapatero , Yilun Sun , Daniel Eidelberg Spratt , Amar Upadhyaya Kishan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Other

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 391)

DOI

10.1200/JCO.2023.41.6_suppl.391

Abstract #

391

Poster Bd #

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

$Biochemical disease control outcomes of stereotactic body radiation therapy (SBRT) or moderate hypo-fractionation (HFRT) for low- and intermediate-risk prostate cancer (PrCa): Retrospective analysis of 12 years of experience at two Canadian cancer centers.$